(trans)-4-((1,8-Dimethyl-2-oxo-6-(thiazol-5-yl)-1,2-dihydroquinolin-4-yl)amino)-N-methylcyclohexanecarboxamide

ID: ALA3426067

Chembl Id: CHEMBL3426067

PubChem CID: 118736887

Max Phase: Preclinical

Molecular Formula: C22H26N4O2S

Molecular Weight: 410.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CNC(=O)[C@H]1CC[C@H](Nc2cc(=O)n(C)c3c(C)cc(-c4cncs4)cc23)CC1

Standard InChI:  InChI=1S/C22H26N4O2S/c1-13-8-15(19-11-24-12-29-19)9-17-18(10-20(27)26(3)21(13)17)25-16-6-4-14(5-7-16)22(28)23-2/h8-12,14,16,25H,4-7H2,1-3H3,(H,23,28)/t14-,16-

Standard InChI Key:  DOPAYNPSNQQSRM-KOMQPUFPSA-N

Alternative Forms

  1. Parent:

    ALA3426067

    ---

Associated Targets(Human)

CD38 Tclin Lymphocyte differentiation antigen CD38 (364 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cd38 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (87 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 410.54Molecular Weight (Monoisotopic): 410.1776AlogP: 3.69#Rotatable Bonds: 4
Polar Surface Area: 76.02Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.84CX LogP: 1.76CX LogD: 1.76
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.69Np Likeness Score: -0.88

References

1. Haffner CD, Becherer JD, Boros EE, Cadilla R, Carpenter T, Cowan D, Deaton DN, Guo Y, Harrington W, Henke BR, Jeune MR, Kaldor I, Milliken N, Petrov KG, Preugschat F, Schulte C, Shearer BG, Shearer T, Smalley TL, Stewart EL, Stuart JD, Ulrich JC..  (2015)  Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors.,  58  (8): [PMID:25828863] [10.1021/jm502009h]

Source